MM
Maria-Bernadette Madel
Director of Corporate Operations & External CommunicationsDr. Maria-Bernadette Madel, Ph.D., is Director of Corporate Operations & External Communications of Marker Therapeutics, Inc. from December 2023. Dr. Madel joined Marker Therapeutics, Inc in 2022 after accruing valuable experience in academic institutions, including Baylor College of Medicine. Dr. Madel earned a B.Sc. and M.Sc. in Molecular Medicine from the Medical University of Innsbruck, Austria and a Ph.D. in Immunology and Microbiology from the University Côte d’Azur, Nice, France.
Positions
- Company NameMarker Therapeutics, Inc.Stock CodeMRKRPositionDirector of Corporate Operations & External CommunicationsColleagues
- JFJuan F. VeraCo-Founder, CEO, President, Treasurer, Secretary & Director
- NDNorman David EansorIndependent Chairman
- EDElizabeth DonnellyDirector of Administration
- ECEdmund CheungVice President of Human Resources
- PAPatricia AllisonHead of Clinical Operations
- KKKatharine KnobilIndependent Director
- MKMalcolm K. BrennerMember of Scientific Advisory Board
- HEHelen E. HeslopMember of Scientific Advisory Board
